290 related articles for article (PubMed ID: 15851524)
21. Evolving concepts of rheumatoid arthritis.
Firestein GS
Nature; 2003 May; 423(6937):356-61. PubMed ID: 12748655
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies in rheumatoid arthritis: a review.
Mewar D; Wilson AG
Biomed Pharmacother; 2006 Dec; 60(10):648-55. PubMed ID: 17064873
[TBL] [Abstract][Full Text] [Related]
23. T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis.
Beech JT; Andreakos E; Ciesielski CJ; Green P; Foxwell BM; Brennan FM
Arthritis Res Ther; 2006; 8(6):R168. PubMed ID: 17101049
[TBL] [Abstract][Full Text] [Related]
24. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
Thurlings RM; Vos K; Gerlag DM; Tak PP
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of T-lymphocytic activity tested by E rosettes test for rheumatoid arthritis (author's transl)].
Scarpa R; Postiglione L; Riccio A; Cutolo M; Oriente P
Quad Sclavo Diagn; 1980 Mar; 16(1):1-6. PubMed ID: 6972543
[TBL] [Abstract][Full Text] [Related]
26. Different modes of action of high-dose immunoglobulins in rheumatoid arthritis.
Delire M
Acta Univ Carol Med (Praha); 1994; 40(1-4):95-9. PubMed ID: 9355681
[TBL] [Abstract][Full Text] [Related]
27. Limited VH gene usage in B-cell clones established with nurse-like cells from patients with rheumatoid arthritis.
Nakamura-Kikuoka S; Takahi K; Tsuboi H; Toyosaki-Maeda T; Maeda-Tanimura M; Wakasa C; Kikuchi N; Norioka S; Iwasaki M; Matsutani T; Itoh T; Yamane S; Takemoto H; Tsuruta Y; Shimaoka Y; Yukioka M; Suzuki R; Ochi T
Rheumatology (Oxford); 2006 May; 45(5):549-57. PubMed ID: 16368734
[TBL] [Abstract][Full Text] [Related]
28. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
[TBL] [Abstract][Full Text] [Related]
29. Synovial fluid estrogens in rheumatoid arthritis.
Cutolo M; Villaggio B; Seriolo B; Montagna P; Capellino S; Straub RH; Sulli A
Autoimmun Rev; 2004 Mar; 3(3):193-8. PubMed ID: 15110231
[TBL] [Abstract][Full Text] [Related]
30. Dunlop-Dottridge lecture. Rehumatoid arthritis, rheumatoid factor and the Epstein-Barr virus.
Vaughan JH
J Rheumatol; 1979; 6(4):381-8. PubMed ID: 230349
[No Abstract] [Full Text] [Related]
31. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
[TBL] [Abstract][Full Text] [Related]
32. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
Tian X; Zhao Y; Li ZG
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
[TBL] [Abstract][Full Text] [Related]
33. Rheumatoid factors: good or bad for you?
Nowak UM; Newkirk MM
Int Arch Allergy Immunol; 2005 Oct; 138(2):180-8. PubMed ID: 16210858
[TBL] [Abstract][Full Text] [Related]
34. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
35. Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.
Brezinschek HP; Brickmann K; Yazdani-Biuki B; Dörner T; Graninger WB; Brezinschek RI
Wien Med Wochenschr; 2006 Jan; 156(1-2):61-7. PubMed ID: 16465615
[TBL] [Abstract][Full Text] [Related]
36. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.
Nandakumar KS; Holmdahl R
Arthritis Res Ther; 2006; 8(6):223. PubMed ID: 17254316
[TBL] [Abstract][Full Text] [Related]
37. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
38. Long term treatment of rheumatoid arthritis with rituximab.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
[TBL] [Abstract][Full Text] [Related]
39. Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis.
Nickdel MB; Conigliaro P; Valesini G; Hutchison S; Benson R; Bundick RV; Leishman AJ; McInnes IB; Brewer JM; Garside P
Ann Rheum Dis; 2009 Jun; 68(6):1059-66. PubMed ID: 18635595
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
